Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.
about
Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensisStage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovaniLeishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stressFrequency of drug resistance gene amplification in clinical leishmania strainsUse of antimony in the treatment of leishmaniasis: current status and future directions.Antimony resistance in leishmania, focusing on experimental research.The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genesDrug resistance in visceral leishmaniasis.Leishmania antimony resistance: what we know what we can learn from the field.Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Cutaneous leishmaniasis: therapeutic strategies and future directions.Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.Molecular events leading to death of Leishmania donovani under spermidine starvation after hypericin treatment.
P2860
Q28478242-6DA2944F-95A6-4048-AC1B-A10F8D45B33DQ28539382-5A8DE5E6-8A5F-4DB3-B3DB-BAC925F2C663Q33587372-95941644-3788-437F-A416-4F1A90CD0BB2Q33797614-A694ADF9-2567-4A25-92F8-5210996DC8DAQ34034590-EF2FC0E7-2836-4904-9B2F-0B7293DA8593Q35377767-AF29D3F5-700E-405D-816F-FC7C6C65DB62Q35607561-4E1846C1-7AA9-4D4D-A461-0BC5A8CB3AEDQ37160811-0550ED65-0912-4827-AAA7-2C2B16053CB4Q37407549-1662E0ED-F9B8-41C6-8D6A-F0916D92C669Q37907925-A75807CB-0738-4B1C-B34F-AF1B7BCC1B45Q38040818-D284694D-0F4E-4FE3-9D04-26E2508A3014Q38872459-C1E4D1AD-4C4C-437A-8096-B5B931B06122Q40037079-384FC759-DB43-4306-A973-3A7D365698C8Q40078925-13AC0657-209D-4702-A5C7-B6C01101BE6AQ40945954-71A935AC-490E-4FDB-BA24-3B271EAADB4EQ42548785-C05C469D-77CB-4064-91CF-6A79C2063DDBQ48137821-B4FA1FCC-3339-4C85-97B7-D8F749CE0F3A
P2860
Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@en
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@nl
type
label
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@en
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@nl
prefLabel
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@en
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@nl
P2093
P2860
P50
P1476
Resistance of Leishmania donov ...... a-glutamylcysteine synthetase.
@en
P2093
P2860
P356
10.1128/AAC.50.1.88-95.2006
P407
P577
2006-01-01T00:00:00Z